default author photo

Mitchell Paul Levesque

University Hospital Zurich - Department of Dermatology

Switzerland

  • University Hospital Zurich - Department of Dermatology

SCHOLARLY PAPERS

3

DOWNLOADS

173

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Combination of the Novel Raf Dimer Inhibitor Brimarafenib with the Mek Inhibitor Mirdametinib is Effective Against Nras Mutant Melanoma

Number of pages: 45 Posted: 09 Sep 2024
Flavia L. Tellenbach, Luzia L. Seiler, Mark Johnson, Hubert Rehrauer, Prachi Schukla, Julia Martinez-Gomez, Corinne I. Stoffel, Adeela Kamal, Reinhard Dummer, Mitchell Paul Levesque and Ossia M. Eichhoff
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Zurich, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University Hospital Zurich - Department of Dermatology, University Hospital Zurich - Department of Dermatology and affiliation not provided to SSRN
Downloads 98 (704,534)

Abstract:

Loading...

Metastatic melanomaRAF dimer inhibitorMAPK pathwaydual inhibitionNRAS mutation

2.

Oncolytic Virotherapy Mediated Anti-Tumor Response: A Single-Cell Perspective

Number of pages: 35 Posted: 06 Aug 2020
Egle Ramelyte, Aizhan Tastanova, Zsolt Balázs, Patrick Turko, Ulrike Menzel, Emmanuella Guenova, Christian Beisel, Michael Krauthammer, Mitchell Paul Levesque and Reinhard Dummer
University Hospital Zurich - Department of Dermatology, University Hospital Zurich - Department of Dermatology, University of Zurich - Department of Quantitative Biomedicine, University Hospital Zurich - Department of Dermatology, ETH Zürich - Department of Biosystems Science and Engineering, University Hospital Zurich - Department of Dermatology, ETH Zürich - Department of Biosystems Science and Engineering, University of Zurich - Department of Quantitative Biomedicine, University Hospital Zurich - Department of Dermatology and University Hospital Zurich - Department of Dermatology
Downloads 38 (1,222,651)

Abstract:

Loading...

Oncolytic virotherapy, non-specific cell infection, single-cell RNA sequencing, single cell immune repertoire profiling, T-VEC induced innate and adaptive immunity, primary cutaneous B-cell lymphoma

3.

Clock-Like Mutation Signature May Be Prognostic for Worse Survival than Signatures of UV Damage in Cutaneous Melanoma

Number of pages: 20 Posted: 18 Apr 2023
Fabienne Fröhlich, Egle Ramelyte, Patrick Turko, Andreas Dzung, Sandra N. Freiberger, Joanna Mangana, Mitchell Paul Levesque and Reinhard Dummer
University Hospital Zurich, University Hospital Zurich - Department of Dermatology, University Hospital Zurich - Department of Dermatology, University Hospital Zurich, University Hospital Zurich, University Hospital Zurich, University Hospital Zurich - Department of Dermatology and University Hospital Zurich - Department of Dermatology
Downloads 37 (1,222,651)

Abstract:

Loading...

clock-like signature, UV signature, COSMIC, mutation profiling, rapid progression